ETF Managers Group, LLC Brainstorm Cell Therapeutics Inc. Transaction History

ETF Managers Group, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $344,097 - $458,415	-114,318 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.46 - $7.88 $70,639 - $160,878	20,416 Added 21.74%	114,318 $424,000
Q4 2020 Feb 16, 2021	BUY	$3.99 - $17.73 $148,767 - $661,063	37,285 Added 65.85%	93,902 $435,000
Q3 2020 Nov 16, 2020	BUY	$11.19 - $16.92 $49,247 - $74,464	4,401 Added 8.43%	56,617 $917,000
Q2 2020 Aug 14, 2020	SELL	$4.42 - $12.66 $61,796 - $176,999	-13,981 Reduced 21.12%	52,216 $579,000

Q1 2020 May 14, 2020	BUY	$4.01 - $8.88 $23,594 - $52,249	5,884 Added 9.76%	66,197 $299,000
Q4 2019 Feb 14, 2020	SELL	$3.62 - $4.29 $30,169 - $35,752	-8,334 Reduced 12.14%	60,313 $259,000
Q3 2019 Nov 14, 2019	BUY	$3.54 - $4.48 $92,737 - $117,362	26,197 Added 61.71%	68,647 $266,000
Q2 2019 Aug 14, 2019	SELL	$3.59 - $4.3 $79,913 - $95,718	-22,260 Reduced 34.4%	42,450 $169,000
Q1 2019 May 07, 2019	SELL	$3.37 - $4.34 $7,033 - $9,057	-2,087 Reduced 3.12%	64,710 $281,000
Q4 2018 Feb 01, 2019	BUY	$2.98 - $3.9 $85,850 - $112,355	28,809 Added 75.84%	66,797 $237,000
Q3 2018 Nov 14, 2018	BUY	$3.73 - $4.38 $33,331 - $39,139	8,936 Added 30.76%	37,988 $145,000
Q2 2018 Aug 14, 2018	SELL	$3.12 - $5.19 $3,123 - $5,195	-1,001 Reduced 3.33%	29,052 $102,000
Q1 2018 May 15, 2018	BUY	$3.01 - $3.77 $15,074 - $18,880	5,008 Added 20.0%	30,053 $96,000
Q4 2017 Feb 14, 2018	BUY	$2.96 - $4.42 $17,049 - $25,459	5,760 Added 29.87%	25,045 $91,000
Q3 2017 Nov 14, 2017	BUY	$3.98 - $4.36 $76,754 - $84,082	19,285	19,285 $79,000

4.09M

63.2K

800

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $12.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.